Top 10 search results for "cancer etm" in Treatments. To see all results and access other features, sign up for free.

Camcevi ETM (Leuprolide) for Prostate Cancer

Overview
Camcevi ETM is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with advanced prostate cancer. Camcevi ETM is also known by its drug name, leuprolide.

Leuprolide is a…

Nubeqa (Darolutamide) for Prostate Cancer

Overview
Nubeqa is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult men with nonmetastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate…

Xtandi (Enzalutamide) for Prostate Cancer

Overview
Xtandi is approved by the U.S. Food and Drug Administration (FDA) to treat several forms of prostate cancer, including castration-resistant prostate cancer (CRPC), metastatic castration-sensitive prostate cancer…

Erleada (Apalutamide) for Prostate Cancer

Overview
Erleada is approved by the U.S. Food and Drug Administration (FDA) to treat metastatic castration-sensitive prostate cancer (mCSPC) and nonmetastatic castration-resistant prostate cancer (nmCSPC). When taking…

Talzenna (Talazoparib) for Prostate Cancer

Overview
Talzenna is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with metastatic (advanced) castration-resistant prostate cancer (mCRPC) that carries mutations (variations) in genes…

Lynparza (Olaparib) for Prostate Cancer

Overview
Lynparza is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) that has either germline or somatic mutations…

Zoladex (Goserelin) for Prostate Cancer

Overview
Zoladex is approved by the U.S. Food and Drug Administration (FDA) for the management of prostate cancer. It is specifically indicated for use in combination with flutamide for individuals with locally confined…

Rubraca (Rucaparib) for Prostate Cancer

Overview
Rubraca is approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic castration-resistant prostate cancer (mCRPC) in adults who have a BRCA gene mutation (change) and who have…

Firmagon (Degarelix) for Prostate Cancer

Overview
Firmagon is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced prostate cancer. It is used as a form of androgen deprivation therapy (ADT) to reduce testosterone levels, which…

Orgovyx (Relugolix) for Prostate Cancer

Overview
Orgovyx is approved by the U.S. Food and Drug Administration (FDA) for the treatment of advanced prostate cancer in adults. It is used as a form of androgen deprivation therapy (ADT) to reduce the levels of…